What if you invested $1,000 in Novo Nordisk in 2010? (Inflation-Adjusted)
NVO · Healthcare · Adjusted to 2026 dollars using BLS CPI-U data
View nominal (non-adjusted) versionNovo Nordisk turned $1,000 into $7,651 between 2010 and today. Impressive on paper, but inflation over that span came to 53% (BLS CPI-U). Adjusted for that erosion in purchasing power, your real gain in constant 2010 dollars is $5,001, which works out to a +10.4% annualized real growth rate over 16 years.
Nominal final value
$7,651
+665.1% total return
Real value (2010 dollars)
$5,001
+400.1% real total return
Real annualized return
+10.4%
vs. +13.3% nominal annualized
Year-by-Year (Inflation-Adjusted)
$1,000 in Novo Nordisk since 2010, values in constant 2010 dollars
| Year | Nominal Value | Real Value (2010 $) |
|---|---|---|
| 2010 | $1,000 | $1,000 |
| 2011 | $1,708 | $1,641 |
| 2012 | $1,826 | $1,719 |
| 2013 | $2,874 | $2,649 |
| 2014 | $3,153 | $2,864 |
| 2015 | $3,608 | $3,278 |
| 2016 | $4,595 | $4,114 |
| 2017 | $3,056 | $2,677 |
| 2018 | $4,832 | $4,106 |
| 2019 | $4,191 | $3,479 |
| 2020 | $5,555 | $4,538 |
| 2021 | $6,495 | $5,052 |
| 2022 | $9,505 | $6,771 |
| 2023 | $13,406 | $9,200 |
| 2024 | $22,453 | $14,969 |
| 2025 | $16,707 | $10,920 |
| 2026 | $12,082 | $7,896 |
Inflation adjustment uses BLS CPI-U annual data, deflated to 2026 dollars. Nominal stock data from Yahoo Finance (split-adjusted closing prices). Real values are expressed in constant 2010 purchasing-power dollars. For informational and educational purposes only. Not financial advice. Past performance does not guarantee future results. See our methodology and full disclaimer.